[February 07, 2017] |
|
Malignant Mesothelioma - Market Insights, Epidemiology & Forecasts - 2023 - Research and Markets
Research and Markets has announced the addition of the "Malignant
Mesothelioma - Market Insights, Epidemiology and Market Forecast - 2023
- EU5" drug pipelines to their offering.
Malignant mesothelioma is a deadly and rare form of cancer that affects
the thin lining known as the mesothelium. Mesothelioma helps to protect
the organs by making a special lubricating fluid that allows organs to
move against each other. Malignant mesothelioma is a rare,
asbestos-related cancer that forms on the thin protective tissues that
cover the lungs and abdomen. It is a deadly disease as its prognosis is
poor and the survival time after diagnosis is around 9-12 months.
Based on the organ which is first affected, mesothelioma can be divided
into several categories:
-
Pleural Mesothelioma: It affects lining of lungs. It is the most
common type of mesothelioma and is caused by the inhalation of
asbestos fibers. About 70% of the mesothelioma cases fall under this
category.
-
Peritoneal Mesothelioma: It affects the lining of abdomen. About 15-20
% cases of mesothelioma are diagnosed as peritoneal.
-
Pericardial Mesothelioma: It affects the lining of heart. Asbestos
fibers can get lodged in th pericardium which is the lining around
the heart cavity. It's a rare kind of mesothelioma which occurs in 1 %
or less number of cases.
-
Tunic vaginalis: It affects the testicles. This is also a rare kind of
mesothelioma.
Scope of the Report:
-
Report covers the disease overview including pathophysiology,
symptoms, diagnosis, disease management, and current treatment options.
-
Marketed information including available prescription drugs, its
patent and exclusivity details.
-
The report also covers the detailed global historical and forecasted
epidemiological data covering 7MM from 2010-2023.
-
It also provides Market size of Malignant mesothelioma for 7MM from
2010 and forecasted Market size to 2023.
Key Topics Covered:
-
Report Introduction
-
Malignant mesothelioma Market Overview at a Glance
-
Total Market Size of Malignant mesothelioma for 7 MM in 2013-2023
-
Total Market Share Distribution of Malignant mesothelioma for 7 MM in
2015
-
Total Market Share Distribution of Malignant mesothelioma for 7 MM in
2023
-
Overview
-
Symptoms
-
Pathophysiology
-
Staging
-
Diagnosis
-
Treatment
-
Epidemiology and Patient Population
-
Diagnosed Cases of Malignant mesothelioma in United States
-
Diagnosed Cases of Malignant mesothelioma in Germany
-
Diagnosed Cases of Malignant mesothelioma in France
-
Diagnosed Cases of Malignant mesothelioma in United Kingdom
-
Diagnosed Cases of Malignant mesothelioma in Spain
-
Diagnosed Cases of Malignant mesothelioma in Italy
-
Diagnosed Cases of Malignant mesothelioma in Japan
-
Top Marketed Drugs for Malignant mesothelioma
-
Market Drivers
-
Market Restraints
-
Appendix
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/35pk8x/malignant
View source version on businesswire.com: http://www.businesswire.com/news/home/20170207005779/en/
[ Back To TMCnet.com's Homepage ]
|